Lista de obras - Sharon E Frey - Dominio Público Uruguay

A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA ⬇️

artículo científico publicado el 3 de agosto de 2013

A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 February 1996

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans

artículo científico publicado en 2013

A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults

artículo científico publicado en 2014

A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).

artículo científico publicado en 2017

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects

artículo científico publicado en 2011

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers

artículo científico publicado en 2011

A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection

artículo científico publicado en 2011

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial ⬇️

artículo científico publicado el 19 de marzo de 2013

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues

artículo científico publicado en 2010

Analysis of Variola and Vaccinia Virus Neutralization Assays for Smallpox Vaccines ⬇️

artículo científico publicado el 16 de mayo de 2012

Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity

artículo científico publicado en 2015

Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development

artículo científico publicado en 2019

Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax

artículo científico publicado en 2007

Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals

artículo científico publicado en 2018

Antibody responses to vaccinia membrane proteins after smallpox vaccination

artículo científico publicado en 2007

Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials

artículo científico publicado en 2014

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine

artículo científico publicado en 2017

Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers

artículo científico publicado en 2001

CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus–Vaccinated Humans ⬇️

artículo científico publicado el 10 de mayo de 2013

COVID-19 Teaches Hard Lessons

artículo científico publicado en 2020

Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series

artículo científico publicado en 2018

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

artículo científico publicado en 2015

Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.

artículo científico publicado en 2010

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults ⬇️

artículo científico publicado el 1 de noviembre de 2010

Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge

artículo científico publicado en 2007

Clinical guidance for smallpox vaccine use in a postevent vaccination program

artículo científico publicado en 2015

Clinical responses to undiluted and diluted smallpox vaccine

artículo científico publicado en 2002

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

artículo científico publicado en 2007

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

artículo científico publicado en 2015

Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults

artículo científico publicado en 2008

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects

artículo científico publicado en 2014

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults ⬇️

artículo científico publicado el 1 de octubre de 2003

Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Networ

artículo científico publicado en 1992

Dose-dependent neutralizing-antibody responses to vaccinia

artículo científico publicado en 2004

Dose-related effects of smallpox vaccine

artículo científico publicado en 2002

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

artículo científico publicado en 2006

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

artículo científico publicado en 2015

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

artículo científico publicado en 2020

Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination

artículo científico publicado en 2009

Evaluation of smallpox vaccines using variola neutralization

artículo científico publicado en 2009

Evidence for probable sexual transmission of the hepatitis g virus

artículo científico publicado en 2002

Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures

scientific article published on 23 January 2020

Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions

artículo científico publicado en 2005

Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial

artículo científico publicado en 2013

Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses

artículo científico publicado en 2013

HIV vaccines.

artículo científico publicado en 1999

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 February 1995

High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects

article

Immune status in a primary smallpox vaccinee who failed to develop an immunization site reaction

artículo científico publicado en 2005

Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older

artículo científico publicado en 2021

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

artículo científico publicado en 2011

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

artículo científico

Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine

artículo científico publicado en 2003

In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.

artículo científico publicado en 2009

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination

artículo científico publicado en 2004

Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

article

Lack of transmission of vaccinia virus

artículo científico publicado en 2006

Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines

artículo científico publicado en 2004

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials

artículo científico publicado en 2003

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado el 1 de enero de 1992

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 March 1998

Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units

artículo científico publicado en 2019

New smallpox vaccines for an ancient scourge

artículo científico publicado en 2014

Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus

artículo científico publicado en 2010

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

artículo científico publicado en 2011

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

artículo científico publicado en 2007

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

artículo científico publicado en 2014

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

artículo científico publicado en 2014

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

artículo científico publicado en 2014

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

artículo científico publicado en 2014

Possible autoimmune reactions following smallpox vaccination: the biologic false positive test for syphilis

scientific article published on 18 November 2008

Poxvirus zoonoses--putting pocks into context

artículo científico publicado en 2004

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

artículo científico publicado en 2016

Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review ⬇️

artículo científico publicado el 17 de enero de 2013

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women

article

Rapid Establishment of a COVID-19 Convalescent Plasma Program in a Regional Healthcare Delivery Network

artículo científico publicado en 2020

Rapid, Sensitive Recovery of Recombinant Attenuated Salmonella enterica Serovar Typhi Vaccine Strains from Human Blood ⬇️

artículo científico publicado el 24 de julio de 2013

Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization

artículo científico publicado en 2014

Response to smallpox vaccine in persons immunized in the distant past

artículo científico publicado en 2003

Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia

artículo científico publicado en 2017

Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine

artículo científico publicado en 2014

Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly

article

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

artículo científico publicado en 2015

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

artículo científico publicado en 2015

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

artículo científico publicado en 2012

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

artículo científico publicado en 2010

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

artículo científico publicado en 2013

Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults

artículo científico publicado en 2011

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

artículo científico publicado en 2008

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

artículo científico publicado en 2001

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

artículo científico publicado en 2002

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

artículo científico

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

artículo científico publicado en 2011

Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women

scientific article published on 08 November 2018

Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants

artículo científico publicado en 2020

Safety profile of recombinant canarypox HIV vaccines

artículo científico publicado en 2004

Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B

artículo científico publicado en 2002

Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine

artículo científico publicado en 2015

Stability of Undiluted and Diluted Vaccinia‐Virus Vaccine, Dryvax ⬇️

artículo científico publicado el 2 de abril de 2003

The immunogenetics of smallpox vaccination.

artículo científico publicado en 2007

The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks

artículo científico publicado en 2009

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

artículo científico publicado en 2017

Unique risks to volunteers in HIV vaccine trials.

artículo científico publicado en 2003

Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020

artículo científico publicado en 2021

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

Variability in the Management of Adults with Pulmonary Nontuberculous Mycobacterial Disease

scientific article published on 21 March 2020

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone

artículo científico publicado en 2010

Lista de obras de Sharon E Frey

A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA ⬇️

A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans

A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults

A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers

A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial ⬇️

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues

Analysis of Variola and Vaccinia Virus Neutralization Assays for Smallpox Vaccines ⬇️

Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity

Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development

Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax

Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals

Antibody responses to vaccinia membrane proteins after smallpox vaccination

Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine

Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers

CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus–Vaccinated Humans ⬇️

COVID-19 Teaches Hard Lessons

Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults ⬇️

Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge

Clinical guidance for smallpox vaccine use in a postevent vaccination program

Clinical responses to undiluted and diluted smallpox vaccine

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults ⬇️

Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Networ

Dose-dependent neutralizing-antibody responses to vaccinia

Dose-related effects of smallpox vaccine

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination

Evaluation of smallpox vaccines using variola neutralization

Evidence for probable sexual transmission of the hepatitis g virus

Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures

Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions

Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial

Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses

HIV vaccines.

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network

High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects

Immune status in a primary smallpox vaccinee who failed to develop an immunization site reaction

Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine

In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination

Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

Lack of transmission of vaccinia virus

Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units

New smallpox vaccines for an ancient scourge

Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

Possible autoimmune reactions following smallpox vaccination: the biologic false positive test for syphilis

Poxvirus zoonoses--putting pocks into context

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review ⬇️

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women

Rapid Establishment of a COVID-19 Convalescent Plasma Program in a Regional Healthcare Delivery Network